Clinical Trial Update: Comparison of Nab-Paclitaxel Versus Paclitaxel in Neoadjuvant Immunochemotherapy Therapy for Esophageal Squamous Cell Carcinoma: A Retrospective IPTW-Adjusted Analysis

View source ↗

Summary

A retrospective IPTW-adjusted analysis compares nab-paclitaxel versus paclitaxel in neoadjuvant immunochemotherapy for esophageal squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Sichuan University | Conditions: Esophageal Cancer | Status: COMPLETED